dr. davids on ipilimumab for hematologic malignancy treatment
Published 9 years ago • 85 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
2:31
dr. davids on checkpoint blockade inhibition in hematologic malignancies after stem cell transplant
-
1:38
ipilimumab, rather than nivolumab for relapsed heme malignancies post allo-sct
-
3:24
ipilimumab side effect management in melanoma
-
1:47
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
1:07
dr. davids on the potential utility of ibrutinib/umbralisib in mcl and cll
-
1:08
dr. michael rotkowitz on ipilimumab plus dacarbazine for metastatic melanoma
-
1:10
dr. ribas on the efficacy of ipilimumab in melanoma
-
0:53
dr. rosenberg on dosing of nivolumab plus ipilimumab in bladder cancer
-
0:40
dr. schuchter discusses managing ipilimumab's side effects
-
1:31
dr. matthew davids on advances in cll
-
1:17
dr. shoushtari on the role of nivolumab and ipilimumab in mucosal melanoma
-
1:30
matthew davids, md, on how checkpoint inhibitors are being developed for hematologic malignancies
-
2:06
dr. puzanov on t-vec in combination with ipilimumab for melanoma treatment
-
2:02
dr. jedd wolchok on concurrent ipilimumab and nivolumab in advanced melanoma
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
-
1:38
dr. sosman on the mechanism of action of ipilimumab in melanoma
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
0:46
dr. kluger on a phase i trial of concurrent nivolumab and ipilimumab for advanced melanoma
-
1:07
dr. galsky on ipilimumab in bladder cancer